chithandizo chachikulu cha khansa ya m'mapapo ya m'mapapo

Khansara Yaikulu Yam'mapapo (LCLC) ndi mtundu wowopsa wa khansa ya m'mapapo yopanda cell yaying'ono (NSCLC). Njira zochizira nthawi zambiri zimaphatikizapo kuphatikiza maopaleshoni, chemotherapy, chithandizo cha radiation, chithandizo chomwe mukufuna, ndi immunotherapy, zogwirizana ndi siteji ya wodwala aliyense, thanzi lake lonse, komanso mawonekedwe enaake otupa. Kupita patsogolo kwaposachedwa kwa mbiri ya maselo ndi mankhwala opangidwa ndi munthu payekha kukuyenda bwino kwa omwe ali ndi LCLC.Chithandizo chachikulu cha khansa ya m'mapapo (LCLC) ndi mtundu wa khansa ya m'mapapo yosakhala yaying'ono. Dzinali limachokera ku maselo akuluakulu, osawoneka bwino omwe amawonedwa ndi maikulosikopu. LCLC imakonda kukula ndikufalikira mwachangu, zomwe zimapangitsa kuzindikira koyambirira komanso chithandizo chofunikira. Ngakhale kuti ndizochepa kwambiri kusiyana ndi mitundu ina ya NSCLC, kumvetsetsa makhalidwe ake n'kofunika kuti muyang'anire bwino.Zowopsa ndi Kupewa Zofanana ndi khansa zina za m'mapapo, kusuta ndiko kumayambitsa chiopsezo cha LCLC. Zinthu zina zowopsa ndizo kusuta fodya, radoni, asibesitosi, ndi zinthu zina za m’mafakitale. Kusiya kusuta, kupeŵa kukhudzana ndi mankhwala omwe amadziwika bwino, komanso kukhala ndi moyo wathanzi ndizo njira zabwino kwambiri zodzitetezera. Kuwunika pafupipafupi komanso kuyezetsa khansa ya m'mapapo kwa anthu omwe ali pachiwopsezo chachikulu kungathandizenso kuti azindikire msanga komanso kuwongolera. chithandizo chachikulu cha khansa ya m'mapapo zotsatira.Zosankha Zochizira Khansa Yaikulu Yam'mapapo Opaleshoniyo nthawi zambiri imakhala njira yoyamba yothandizira LCLC yoyambilira, pomwe chotupacho chimapezeka ndipo sichinafalikire kumadera akutali. Opaleshoniyo ingaphatikizepo kuchotsa gawo la mapapo (wedge resection kapena segmentectomy), lobe lonse (lobectomy), kapena mapapu onse (pneumonectomy). Kusankhidwa kwa opaleshoni kumadalira kukula ndi malo a chotupacho, komanso ntchito ya m'mapapo ya wodwalayo. Magulu ochita opaleshoni a Shandong Baofa Cancer Research Institute ndi odziwa zambiri m'njirazi.ChemotherapyChemotherapy ndi chithandizo chadongosolo chomwe chimagwiritsa ntchito mankhwala kupha maselo a khansa mthupi lonse. Nthawi zambiri amagwiritsidwa ntchito limodzi ndi opaleshoni kapena ma radiation therapy, kapena ngati chithandizo choyambirira cha LCLC yapamwamba. Njira zodziwika bwino za chemotherapy za LCLC zimaphatikizapo mankhwala opangidwa ndi platinamu (monga cisplatin kapena carboplatin) ophatikizidwa ndi othandizira ena a chemotherapy. Zotsatira za chemotherapy zingaphatikizepo nseru, kutopa, kutayika tsitsi, ndi chiopsezo chowonjezereka cha matenda.Radiation TherapyRadiation therapy imagwiritsa ntchito kuwala kwamphamvu kwambiri kuti iwononge ndi kuwononga maselo a khansa. Ikhoza kugwiritsidwa ntchito pochiza LCLC m'njira zingapo: monga chithandizo choyambirira kwa odwala omwe sali oyenerera opaleshoni, monga chithandizo chothandizira pambuyo pa opaleshoni kuti aphe maselo a khansa otsala, kapena kuchepetsa zizindikiro monga kupweteka kapena kupuma movutikira mu matenda apamwamba. Mitundu ya ma radiation omwe amagwiritsidwa ntchito pa LCLC ndi monga kunja kwa beam radiation therapy (EBRT) ndi stereotactic body radiation therapy (SBRT). Mankhwalawa ndi othandiza makamaka kwa odwala omwe ali ndi kusintha kwachibadwa m'matumbo awo. Zolinga zodziwika mu LCLC ndi EGFR, ALK, ROS1, ndi BRAF. Asanayambe chithandizo chomwe akufuna, odwala nthawi zambiri amayesedwa kuti adziwe ngati zotupa zawo zili ndi masinthidwe ena. Ngati mukufuna thandizo, Bungwe la Baofa Cancer Research Institute lingapereke chithandizo choyezera ma genetic.ImmunotherapyImmunotherapy imagwiritsa ntchito mphamvu zachitetezo cha thupi kuti kulimbana ndi khansa. Immune checkpoint inhibitors, monga pembrolizumab, nivolumab, ndi atezolizumab, ndi mtundu wa immunotherapy womwe umatsekereza mapuloteni omwe amalepheretsa chitetezo chamthupi kuukira maselo a khansa. Immunotherapy yawonetsa zotsatira zabwino pochiza LCLC, makamaka kwa odwala omwe zotupa zawo zimawonetsa kuchuluka kwa PD-L1. Itha kugwiritsidwa ntchito ngati chithandizo choyambirira cha LCLC yapamwamba kapena pambuyo poti chemotherapy yalephera.Kupita patsogolo kwa Maselo Akuluakulu a Khansa Yam'mapapoMolecular ProfilingKulemba kwa molecular kumaphatikizapo kufufuza minofu ya chotupa cha wodwala kuti azindikire kusintha kwa majini kapena kusintha kwina kwa maselo omwe angakhale akuyendetsa kukula kwa khansa. Chidziwitsochi chingathandize madokotala kusankha njira yoyenera kwambiri yothandizira kapena immunotherapy kwa wodwala aliyense. Next-generation sequencing (NGS) ndi njira yodziwika bwino yomwe imagwiritsidwa ntchito polemba mbiri ya mamolekyulu, kulola kuzindikirika kwakanthawi kosinthika kwamitundu yambiri. chithandizo chachikulu cha khansa ya m'mapapo kwa wodwala payekhapayekha potengera momwe chotupacho chilili, thanzi lawo lonse, komanso zomwe amakonda. Njirayi ikufuna kupititsa patsogolo chithandizo chamankhwala ndikuchepetsa zotsatira zake. Mankhwala aumwini akukhala ofunika kwambiri mu kayendetsedwe ka LCLC, chifukwa amalola madokotala kusankha njira yoyenera yothandizira wodwala aliyense.Mayesero a Zachipatala Mayesero achipatala ndi maphunziro ofufuza omwe amayesa mankhwala atsopano kapena mankhwala osakaniza a LCLC. Kutenga nawo gawo pazachipatala kungapereke odwala mwayi wopeza chithandizo chamakono chomwe sichinapezekebe. Mayesero a zachipatala ndi gawo lofunika kwambiri la kupititsa patsogolo chisamaliro cha khansa, ndipo odwala ayenera kukambirana ndi madokotala awo ngati kutenga nawo mbali mu mayesero a zachipatala ndi njira yabwino kwa iwo.Prognosis and Survival RatesKudziwikiratu kwa LCLC kumasiyana malinga ndi zifukwa zingapo, kuphatikizapo siteji ya khansa pa matenda, thanzi lonse la wodwalayo, ndi yankho la chithandizo. LCLC yoyambirira yomwe imachiritsidwa ndi opaleshoni imakhala ndi chidziwitso chabwino kuposa LCLC yapamwamba yomwe yafalikira kumadera akutali. Kupita patsogolo kwa chithandizo, monga chithandizo chamankhwala ndi immunotherapy, kwathandizira kupulumuka kwa odwala omwe ali ndi LCLC m'zaka zaposachedwa. Zaka 5 za Kupulumuka kwa Khansa Yam'mapapo Yosakhala Yaing'ono (NSCLC) ndi Stage1 Stage 5-Year Survival Rate Localized 63% Regional 36% Distant 8% All SEER Stages 26% *Zindikirani: Miyezo yopulumukayi imachokera ku data yochokera ku National Cancer Institute's Surveillance, EpideLiells Surveillance (EpideLie) Programme ya Epideli (EpideLie) ndi EpideLig. Khansa Yam'mapapoKukhala ndi LCLC kungakhale kovuta, koma pali zinthu zomwe zingathandize odwala ndi mabanja awo kupirira zovuta zakuthupi ndi zamaganizo za matendawa. Magulu othandizira, uphungu, ndi chisamaliro chothandizira angapereke chithandizo chofunikira. Kukhala ndi moyo wathanzi, kuphatikizapo kudya zakudya zoyenera komanso kuchita masewera olimbitsa thupi nthawi zonse, kungathandizenso kuti munthu akhale ndi moyo wabwino. Kukambirana zodetsa nkhawa ndi mafunso ndi gulu lanu lazaumoyo ndikofunikira pakuwongolera LCLC moyenera.Kupeza Thandizo ndi ZothandiziraMabungwe ambiri amapereka chithandizo ndi zothandizira kwa anthu omwe ali ndi LCLC ndi mabanja awo. Zothandizira izi zikuphatikiza zida zamaphunziro, magulu othandizira, mapulogalamu othandizira ndalama, ndi zoyeserera zolimbikitsa. Kulumikizana ndi zinthu izi kungapereke chithandizo chofunikira komanso chitsogozo paulendo wonse wa khansa.Zolozera: American Society of Clinical Oncology (ASCO): Khansa Yam'mapapo - Maselo Osakhala Aang'ono: Ziwerengero.